GlassScriptPhysician profile
Todd H Morgan
NPI 1851485957
$2,849.58
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $288 · 2021: $371 · 2022: $315 · 2023: $724 · 2024: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $486.24 | 2019-2024 | Hydrus Microstent, Dailies Total1, Total30 |
| Bausch & Lomb Americas INC. | $292.88 | 2022-2023 | Miebo, Infuse |
| Coopervision INC. | $269.78 | 2019-2024 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $243.70 | 2023-2024 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $240.02 | 2024 | Tecnis Iol |
| Aerie Pharmaceuticals, INC. | $224.60 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $199.36 | 2019-2021 | |
| Horizon Therapeutics Plc | $180.15 | 2022-2023 | Tepezza |
| Maculogix, INC. | $141.11 | 2019 | |
| Spark Therapeutics, INC. | $121.85 | 2021 | |
| Oyster Point Pharma, INC. | $99.06 | 2023 | Tyrvaya |
| Lombart Brothers, INC. | $92.72 | 2020 | |
| Genentech USA, INC. | $90.23 | 2020 | |
| Samsara Vision | $63.90 | 2022 | |
| Abb Con-Cise Optical Group LLC | $40.62 | 2019-2024 | Spectacle Lenses, Contact Lens |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $26.23 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $25.31 | 2023 | Acuvue |
| Sight Sciences, INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.